Suppr超能文献

乌干达东部和西部镰状细胞性状患病率的最新情况。

An up-date on the prevalence of sickle cell trait in Eastern and Western Uganda.

作者信息

Okwi Andrew L, Byarugaba Wilson, Ndugwa Christopher M, Parkes Arthur, Ocaido Michael, Tumwine James K

机构信息

Department of Pathology, Makerere University, College of Health Sciences, P,O, Box 7072, Kampala, Uganda.

出版信息

BMC Blood Disord. 2010 Jun 23;10:5. doi: 10.1186/1471-2326-10-5.

Abstract

BACKGROUND

The first survey on sickle cell disease (SCD) done in Uganda in 1949, reported the district of Bundibugyo in Western Uganda to have the highest sickle cell trait (SCT) prevalence (45%). This is believed to be the highest in the whole world. According to the same survey, the prevalence of SCT in the districts of Mbale and Sironko in the East was 20-28%, whilst the districts of Mbarara and Ntungamo in the West had 1-5%. No follow-up surveys have been conducted over the past 60 years. SCA accounts for approximately 16.2% of all pediatric deaths in Uganda. The pattern of SCT inheritance, however, predicts likely changes in the prevalence and distribution of the SCT. The objective of the study therefore was to establish the current prevalence of the SCT in Uganda.

METHODS

This study was a cross sectional survey which was carried out in the districts of Mbale and Sironko in the Eastern, Mbarara/Ntungamo and Bundibugyo in Western Uganda. The participants were children (6 months-5 yrs). Blood was collected from each subject and analyzed for hemoglobin S using cellulose acetate Hb electrophoresis.

RESULTS

The established prevalence of the SCT (As) in Eastern Uganda was 17.5% compared to 13.4% and 3% in Bundibugyo and Mbarara/Ntungamo respectively. 1.7% of the children in Eastern Uganda tested positive for haemoglobin ss relative to 3% in Bundibugyo, giving gene frequencies of 0.105 and 0.097 for the recessive gene respectively. No ss was detected in Mbarara/Ntungamo.

CONCLUSIONS

A shift in the prevalence of the SCT and ss in Uganda is notable and may be explained by several biological and social factors. This study offers some evidence for the possible outcome of intermarriages in reducing the incidence of the SCT.

摘要

背景

1949年在乌干达进行的首次镰状细胞病(SCD)调查显示,乌干达西部的本迪布焦区镰状细胞性状(SCT)患病率最高(45%)。据信这是全世界最高的。根据同一项调查,东部的姆巴莱区和锡龙科区SCT患病率为20%-28%,而西部的姆巴拉拉区和恩通加莫区为1%-5%。在过去60年里没有进行后续调查。镰状细胞贫血(SCA)约占乌干达所有儿科死亡病例的16.2%。然而,SCT的遗传模式预示着SCT患病率和分布可能发生变化。因此,本研究的目的是确定乌干达目前SCT的患病率。

方法

本研究是一项横断面调查,在乌干达东部的姆巴莱区和锡龙科区、西部的姆巴拉拉/恩通加莫区和本迪布焦区开展。参与者为儿童(6个月至5岁)。从每个受试者采集血液,并用醋酸纤维素血红蛋白电泳分析血红蛋白S。

结果

乌干达东部确定的SCT(As)患病率为17.5%,而本迪布焦区和姆巴拉拉/恩通加莫区分别为13.4%和3%。乌干达东部1.7%的儿童血红蛋白ss检测呈阳性,而本迪布焦区为3%,隐性基因的基因频率分别为0.105和0.097。在姆巴拉拉/恩通加莫区未检测到ss。

结论

乌干达SCT和ss患病率的变化显著,可能由多种生物学和社会因素解释。本研究为通婚在降低SCT发病率方面的可能结果提供了一些证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff31/2905339/f879ef0296a5/1471-2326-10-5-1.jpg

相似文献

1
An up-date on the prevalence of sickle cell trait in Eastern and Western Uganda.
BMC Blood Disord. 2010 Jun 23;10:5. doi: 10.1186/1471-2326-10-5.
4
Burden of sickle cell trait and disease in the Uganda Sickle Surveillance Study (US3): a cross-sectional study.
Lancet Glob Health. 2016 Mar;4(3):e195-200. doi: 10.1016/S2214-109X(15)00288-0. Epub 2016 Jan 29.
8
The effect of alpha-thalassemia on cord blood red cell indices and interaction with sickle cell gene.
Ann Saudi Med. 2000 Sep-Nov;20(5-6):367-70. doi: 10.5144/0256-4947.2000.367.
9
Prevalence of hemoglobin S trait among blood donors: a cross-sectional study.
BMC Res Notes. 2015 Oct 19;8:583. doi: 10.1186/s13104-015-1583-0.

引用本文的文献

5
Sickle cell trait screening in students in a Ugandan university: a cross-sectional study.
J Int Med Res. 2022 Nov;50(11):3000605221138491. doi: 10.1177/03000605221138491.
7
Prevalence of Sickle Cell Disease Among Anaemic Children Attending Mbeya Referral Hospital in Southern Tanzania.
East Afr Health Res J. 2018;2(2):142-146. doi: 10.24248/EAHRJ-D-18-00015. Epub 2018 Nov 23.
8
Neurocognitive Functioning among Children with Sickle Cell Anemia Attending SCA Clinic at MNH, Dar es Salaam, Tanzania.
Neurol Res Int. 2020 Sep 1;2020:3636547. doi: 10.1155/2020/3636547. eCollection 2020.
9
Management of Iron Overload in Resource Poor Nations: A Systematic Review of Phlebotomy and Natural Chelators.
J Toxicol. 2020 Jan 27;2020:4084538. doi: 10.1155/2020/4084538. eCollection 2020.

本文引用的文献

2
Bone marrow transplantation (BMT) and gene replacement therapy (GRT) in sickle cell anemia.
Niger J Med. 2008 Jul-Aug;17(3):251-6. doi: 10.4314/njm.v17i3.37390.
3
Global epidemiology of haemoglobin disorders and derived service indicators.
Bull World Health Organ. 2008 Jun;86(6):480-7. doi: 10.2471/blt.06.036673.
4
Distribution of the sickle-cell trait in Uganda, and its ethnological significance.
Nature. 1949 Sep 17;164(4168):494. doi: 10.1038/164494a0.
5
Sickle cell disease in Uganda: a time for action.
East Afr Med J. 2003 Jul;80(7):384-7. doi: 10.4314/eamj.v80i7.8724.
6
Mortality from sickle cell disease in Africa.
BMJ. 2005 Feb 26;330(7489):432-3. doi: 10.1136/bmj.330.7489.432.
8
Sickle cell disease in Africa.
Curr Opin Hematol. 2002 Mar;9(2):111-6. doi: 10.1097/00062752-200203000-00005.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验